Chronic inflammation disrupts hormones like insulin, leading to increased fat storage and weight gain
Thursdays announcement comes as the White House is looking to demonstrate that Trump is in touch with Americans frustrations with rising costs for food, housing, health care, and other necessities
However, the differences are minimal and the clinical relevance is unknown
Heise T, Mari A, DeVries JH et al (2022) Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial
Someone needed to set the record straight and I figured it might as well be me
Choosing a GLP-1R agonist is mostly based on what the patient wants